LifeNet Health and DePuy Synthes Launch VertiGraft ACIS VG2: Uniquely Engineered

LifeNet Health and DePuy Synthes have launched VertiGraft ACIS VG2, the first allograft interbody spacer specifically designed for DePuy Synthes’s ACIS instrumentation.

Comprised of a cancellous core and cortical endplates, VertiGraft ACIS VG2 is uniquely engineered to provide mechanical strength, reduce migration, and facilitate early vascularization and bone remodeling.1 It is the latest generation of the VertiGraft portfolio of allograft implants, which have a proven record of clinical effectiveness. A prospective study found 100% fusion rates after 12 months in 74 ACDF patients while facilitating bone growth and remodeling.2

“VertiGraft ACIS VG2 brings together the latest in structural allograft technology with state-of-the-art spinal instrumentation,” said Heather Pierce, General Manager of Global Spine and General Orthopedics at LifeNet Health. “The result is greater efficiency and flexibility for clinicians and effective healing for patients.”

The VertiGraft ACIS VG2 allograft is available in multiple footprints, in both parallel and lordotic configurations to optimize fit, fill, and saggital balance restoration. The cortical endplates provide the necessary strength to support the load of the cervical spine, and the cancellous center allows for early bone and vascular in–growth.1,3 In addition, the chamfered profile is designed for easy insertion. It is processed with LifeNet Health’s Allowash XG® and Preservon® technologies, providing the assurance of medical device-grade sterility with the convenience of room-temperature storage.

Designed and processed by LifeNet Health, VertiGraft ACIS VG2 is available exclusively through DePuy Synthes.


References

1. Fox B, Gopez A, Sukovich W, and Kerner M. Anterior Cervical Spine Fusion Rates Using a Frozen Laminated Composite Allograft and Plating The Internet Journal of Spine Surgery. 2005; 2(1).
2. Abla A, El Kadi H, Bost J, Maroon J, and Wert M. Allograft Composite Cortical and Cancellous Bone Graft for Anterior Cervical Fusion. Contemporary Neurosurgery: A Biweekly Publication for Clinical Neurosurgical Continuing Medical Education. 2005;27(8):1-6.
3. Salter R B. Textbook of Disorders and Injuries of the Musculoskeletal System. 1st ed. Baltimore: Williams & Wilkins; 1970.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The KnowU incorporates the sensor that the Company plans to submit to the FDA for clearance. This proprietary sensor has been tested and proven stable and accurate in the lab setting. It was included in the Company’s prototype to validate stability outside of the lab, and is now miniaturized and wearable.
The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."

By using this website you agree to accept Medical Device News Magazine Privacy Policy